CCR5 and infection: These studies have led to translation of this research into clinical trials, for example, the phase I clinical trial run at the City of Hope Medical Center is administering ZFN CCR5 modified autologous SB-728mR-HSPC to HIV-1 CCR5-utilizing infected patients to assess their safety and feasibility at inhibiting infection with CCR5-utilizing HIV-1.